The latest fresh news regarding the new coronavirus says that following an agreement between various Ministers of Health of the European Union, as many as 400 million doses of the vaccine will be purchased by member states for its distribution, the initial stages of which have been planned for the beginning of the new year.
Beyond the fact that they have already signed a contract for the supply of a product that in fact does not yet exist, based on the production promise of a multinational called "AstraZeneca", I want to focus on some aspects that deviate from the purely health issue, as the distribution of this vaccine will certainly represent for some oligarchies the biggest deal in history since the concept of exchange has existed.
There is no doubt that this will be first of all an economic but also a social event and furthermore, following its distribution on a global scale, will help us to better understand the movements on the international chessboard since many are the States that are investing rivers of money on this. vaccine, both in private and public laboratories. Here the question becomes interesting since there are about 35 pharmaceutical companies that are working on the vaccine, more or less transparently funded by many nations among which the United States, Great Britain, China, Russia, Israel and Australia stand out, which will not want to depend on foreign powers to procure drugs during a pandemic. Added to these are the loans of multibillionaires such as Bill Gates on whom the shadow of a conflict of interest hovers, as recently demonstrated by a report service.
Returning to AstraZeneca, to which many EU governments have entrusted the task of pulling the rabbit out of the hat, it seems that it has hinted that access to the vaccine will be "broad, fair and non-profit".
What I worry most about is not the fact that the value of these three concepts, if really applied, would make a Franciscan monastery look like a top ten pharmaceutical holding by global turnover, but the curriculum certainly not reassuring of this company that has found itself often he is gladly at the center of some scandals typical of this world, linked to indications and contraindications on medicines of their production that are silent or unspecified, little transparency in the purchase of patents, sexual harassment within the chain of command, tax evasion and problems relating to taxation, abuse of dominant position, situations of fraudulent bankruptcy of third-party companies which have turned out to be their own company containers and trade union issues concerning the condition of workers.
